Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pulmonary Embolism × bemiparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Neoplasms 2 Pulmonary Embolism 1 Hemorrhage 1

Interventions

Dalteparin 5 apixaban 3 abelacimab 2 MAA868 2 edoxaban 1 bemiparin 1 Tinzaparin 1 Heparin, Low-Molecular-Weight 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡